Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_provenance.
- NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_assertion description "[The PC-3 tumor cell line has an elevated expression of GRP-Rs (2.5 x 10(5)/cell), whereas LNCaP--a prostate cancer metastatic cell line representing the early androgen-sensitive stage of prostate cancer--and DU145--an androgen-insensitive metastatic line--express lower receptor numbers (5.9 x 10(3) and 1.2 x 10(4)/cell, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_provenance.
- NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_assertion evidence source_evidence_literature NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_provenance.
- NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_assertion SIO_000772 19910427 NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_provenance.
- NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_assertion wasDerivedFrom befree-2016 NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_provenance.
- NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_assertion wasGeneratedBy ECO_0000203 NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_provenance.
- befree-2016 importedOn "2016-02-19" NP775478.RAZlx9cqTsMEBtdsBS3BT4veveAalY1NMCC2Ye_M6hkYM130_provenance.